Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Berk

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Pharmacy|February 1, 1990
Antiplatelet agents in coronary artery diseaseB J Schrader, S I Berk
The American Journal of Cardiology|August 15, 1993
Effect of intravenous nitroglycerin on heparin dosage requirements in coronary artery diseaseS I Berk, A Grunwald, S Pal, et al.
Clinical Pharmacy|January 1, 1988
Estimation of creatinine clearance in malnourished patientsA H Lau, S I Berk, T Prosser, et al.
Journal of Clinical Pharmacology|July 1, 1994
The effect of sucralfate on serum lipids and lipoproteins in normal volunteers [corrected]M H Schwenk, S I Berk, D V Morgan, et al.
The American Journal of Medicine|August 25, 1999
A mesenteric mass in a chronic LSD userS I Berk, R F LeBlond, K B Hodges, et al.
International Journal of Cardiology|January 1, 1987
The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarctionS I Berk, P Gal, J L Bauman, et al.
Pharmacotherapy|January 1, 1992
Comparison of the pharmacokinetics and electrocardiographic effects of sublingual and intravenous verapamilS I Berk, K Beckman, T J Hoon, et al.
American Heart Journal|December 1, 1987
Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcomeJ L Bauman, S I Berk, R J Hariman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Pharmacy|February 1, 1990
Antiplatelet agents in coronary artery diseaseB J Schrader, S I Berk
The American Journal of Cardiology|August 15, 1993
Effect of intravenous nitroglycerin on heparin dosage requirements in coronary artery diseaseS I Berk, A Grunwald, S Pal, et al.
Clinical Pharmacy|January 1, 1988
Estimation of creatinine clearance in malnourished patientsA H Lau, S I Berk, T Prosser, et al.
Journal of Clinical Pharmacology|July 1, 1994
The effect of sucralfate on serum lipids and lipoproteins in normal volunteers [corrected]M H Schwenk, S I Berk, D V Morgan, et al.
The American Journal of Medicine|August 25, 1999
A mesenteric mass in a chronic LSD userS I Berk, R F LeBlond, K B Hodges, et al.
International Journal of Cardiology|January 1, 1987
The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarctionS I Berk, P Gal, J L Bauman, et al.
Pharmacotherapy|January 1, 1992
Comparison of the pharmacokinetics and electrocardiographic effects of sublingual and intravenous verapamilS I Berk, K Beckman, T J Hoon, et al.
American Heart Journal|December 1, 1987
Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcomeJ L Bauman, S I Berk, R J Hariman, et al.
Pageof 1